PortfoliosLab logoPortfoliosLab logo
SNDK vs. RVMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SNDK vs. RVMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sandisk Corporation (SNDK) and Revolution Medicines, Inc. (RVMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SNDK achieves a 787.97% return, which is significantly higher than RVMD's 100.95% return.


SNDK

1D
6.45%
1M
49.75%
YTD
787.97%
6M
944.17%
1Y
4,859.67%
3Y*
5Y*
10Y*

RVMD

1D
4.02%
1M
9.89%
YTD
100.95%
6M
102.61%
1Y
294.33%
3Y*
86.64%
5Y*
35.73%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SNDK vs. RVMD - Yearly Performance Comparison


2026 (YTD)2025
SNDK
Sandisk Corporation
787.97%356.50%
RVMD
Revolution Medicines, Inc.
100.95%92.67%

Correlation

The correlation between SNDK and RVMD is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Feb 24, 2025

0.23

Fundamentals

Market Cap

SNDK:

$330.93B

RVMD:

$31.71B

EPS

SNDK:

$29.70

RVMD:

-$7.17

PB Ratio

SNDK:

24.02

RVMD:

21.14

Total Revenue (TTM)

SNDK:

$13.18B

RVMD:

$0.00

Gross Profit (TTM)

SNDK:

$7.39B

RVMD:

-$4.70M

EBITDA (TTM)

SNDK:

$5.37B

RVMD:

-$1.34B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SNDK vs. RVMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNDK
SNDK Risk / Return Rank: 100100
Overall Rank
SNDK Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
SNDK Sortino Ratio Rank: 9999
Sortino Ratio Rank
SNDK Omega Ratio Rank: 9999
Omega Ratio Rank
SNDK Calmar Ratio Rank: 100100
Calmar Ratio Rank
SNDK Martin Ratio Rank: 100100
Martin Ratio Rank

RVMD
RVMD Risk / Return Rank: 9898
Overall Rank
RVMD Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
RVMD Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMD Omega Ratio Rank: 9898
Omega Ratio Rank
RVMD Calmar Ratio Rank: 9898
Calmar Ratio Rank
RVMD Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNDK vs. RVMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sandisk Corporation (SNDK) and Revolution Medicines, Inc. (RVMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SNDKRVMDDifference
Sharpe ratioReturn per unit of total volatility

+45.17

Sortino ratioReturn per unit of downside risk

+2.84

Omega ratioGain probability vs. loss probability

2.17

1.78

+0.39

Calmar ratioReturn relative to maximum drawdown

157.55

11.88

+145.67

Martin ratioReturn relative to average drawdown

477.29

28.48

+448.81

SNDK vs. RVMD - Sharpe Ratio Comparison

The current SNDK Sharpe Ratio is 49.58, which is higher than the RVMD Sharpe Ratio of 4.41. The chart below compares the historical Sharpe Ratios of SNDK and RVMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SNDK vs. RVMD - Drawdown Comparison

The maximum SNDK drawdown since its inception was -47.50%, smaller than the maximum RVMD drawdown of -73.29%. Use the drawdown chart below to compare losses from any high point for SNDK and RVMD.


Loading charts...

Drawdown Indicators


SNDKRVMDDifference

Max Drawdown

Largest peak-to-trough decline

-47.50%

-73.29%

+25.79%

Max Drawdown (1Y)

Largest decline over 1 year

-31.34%

-24.95%

-6.39%

Max Drawdown (3Y)

Largest decline over 3 years

-48.63%

Max Drawdown (5Y)

Largest decline over 5 years

-57.95%

Current Drawdown

Current decline from peak

0.00%

-2.21%

+2.21%

Average Drawdown

Average peak-to-trough decline

-13.70%

-35.66%

+21.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.32%

10.57%

-0.25%

Volatility

SNDK vs. RVMD - Volatility Comparison

Sandisk Corporation (SNDK) has a higher volatility of 26.29% compared to Revolution Medicines, Inc. (RVMD) at 13.97%. This indicates that SNDK's price experiences larger fluctuations and is considered to be riskier than RVMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SNDKRVMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.29%

13.97%

+12.32%

Volatility (6M)

Calculated over the trailing 6-month period

72.07%

55.20%

+16.87%

Volatility (1Y)

Calculated over the trailing 1-year period

99.78%

67.30%

+32.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

97.60%

62.58%

+35.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

97.60%

65.75%

+31.85%

Dividends

SNDK vs. RVMD - Dividend Comparison

Neither SNDK nor RVMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SNDK vs. RVMD - Financials Comparison

This section allows you to compare key financial metrics between Sandisk Corporation and Revolution Medicines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
5.95B
0
(SNDK) Total Revenue
(RVMD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SNDK and RVMD have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SNDK has higher volatility (26.29%) compared to RVMD (13.97%). In terms of maximum drawdown, SNDK dropped -47.50% vs RVMD's -73.29%.

SNDK currently has the higher Sharpe Ratio (49.58 vs 4.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SNDK and RVMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer